Accel-Ondansetron ODT, Mint-Betahistine and PMS-Pirfenidone tablets recalled due to data integrity concerns

Product safety

Date

2025-06-17

Country

Canada

Product

All lots of Accel-Ondansetron ODT (4 mg and 8 mg tablets); Mint-Betahistine (8 mg, 16 mg and 24 mg tablets);…

Category

Drugs & medical

Source

Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

1. 2025-06-18
2. CA
   Drugs & medicalType I

   Accel-Ondansetron ODT 4 & 8 mg: Data integrity concerns with product's bioequivalence data that could lead to incorrect dosing.

   Product quality

   Health CanadaOfficial notice →
3. 2025-06-17
4. CA
   Drugs & medicalType III

   JuHong TanKe JianGao liquid; missing medicinal ingredient "Glycyrrhiza uralensis" on label

   Product quality

   Health CanadaOfficial notice →
5. CA
   Drugs & medicalType III

   Weiteling tablet; Missing medical ingredient Bletilla striata & incorrect expiry date

   Product quality

   Health CanadaOfficial notice →
6. 2025-06-16
7. CA
   Drugs & medicalType II

   Kimmtrak Solution; Out of specification (in-vitro potency assay)

   Product quality

   Health CanadaOfficial notice →
8. 2025-06-12
9. CA
   Drugs & medicalType II

   Azurion 7 Systems

   Performance

   Health CanadaOfficial notice →
10. CA
    Drugs & medicalType II

    Heyman Follower

    Labelling and packaging

    Health CanadaOfficial notice →